The Role of Striatal Glutamatergic System in Haloperidol-Induced Dopamine Receptor Supersensitivity and Effects of Monosialoganglioside GM1

[1]  B. Sabel,et al.  Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. , 1994, The Journal of pharmacology and experimental therapeutics.

[2]  J. Desce,et al.  Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes , 1994, Neurochemistry International.

[3]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[4]  C. Y. Kao,et al.  Enhancement of beta-adrenergic receptor activation of maxi-K+ channels by GM1 ganglioside. , 1994, Biochemical and biophysical research communications.

[5]  B. Sabel,et al.  A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers , 1994, Neuroscience Letters.

[6]  N. Guzman,et al.  In vivo monitoring of glutamate in the brain by microdialysis and capillary electrophoresis with laser-induced fluorescence detection. , 1993, Journal of chromatography. A.

[7]  B. Lössner,et al.  Glutamate Binding to Brain Membranes Is Increased in Pentylenetetrazole‐Kindled Rats , 1993, Journal of neurochemistry.

[8]  H. Manev,et al.  Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain. , 1992, Neuroreport.

[9]  M. Shifman.  The effect of gangliosides upon recovery of aspartate/glutamatergic synapses in striatum after lesions of the rat sensorimotor cortex , 1991, Brain Research.

[10]  R. Waziri,et al.  Evidence of glutamatergic deficiency in schizophrenia , 1991, Neuroscience Letters.

[11]  K. Reymann,et al.  N-methyl-D-aspartate stimulates the release of dopamine from rat hippocampal slices. , 1990, Biomedica biochimica acta.

[12]  T. Sumi,et al.  Evoked release of endogenous amino acids from rat striatal slices and its modulation. , 1989, European journal of pharmacology.

[13]  G Maura,et al.  Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. , 1988, The Journal of pharmacology and experimental therapeutics.

[14]  B. Sabel,et al.  Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury , 1988, Springer US.

[15]  B. Sabel.  Anatomic Mechanisms Whereby Ganglioside Treatment Induces Brain Repair , 1988 .

[16]  I. Divac,et al.  Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain , 1981, Neuroscience.

[17]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[18]  A. Young,et al.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Svennerholm.  CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.

[20]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.